Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses

Afficher d'autres versions (1)

Détails bibliographiques
Auteurs principaux:	Butters, T, Dwek, R, Platt, F
Format:	Conference item
Publié:	2005

Documents similaires

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
par: Butters, T, et autres
Publié: (2005)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
par: Platt, F, et autres
Publié: (2003)

Iminosugars and methods of treating Arenaviral infections
par: Ramstedt, U, et autres
Publié: (2010)

Iminosugars and methods of treating viral diseases
par: Ramstedt, U, et autres
Publié: (2011)

Iminosugars and methods of treating Filoviral diseases
par: Ramstedt, U, et autres
Publié: (2011)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
par: Ramstedt, U, et autres
Publié: (2010)

Storage solutions: treating lysosomal disorders of the brain.
par: Jeyakumar, M, et autres
Publié: (2005)

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
par: Norris-Cervetto, E, et autres
Publié: (2006)

Therapeutic applications of imino sugars in lysosomal storage disorders.
par: Butters, T, et autres
Publié: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
par: Butters, T, et autres
Publié: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
par: Butters, T, et autres
Publié: (2000)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
par: Jeyakumar, M, et autres
Publié: (2002)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
par: Butters, T, et autres
Publié: (2003)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease
par: Boucheron, C, et autres
Publié: (2005)

Iminosugar for treatment of tumors
par: Dwek, R, et autres
Publié: (2008)

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
par: Durantel, D, et autres
Publié: (2001)

Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
par: Boomkamp, S, et autres
Publié: (2010)

Iminosugar antivirals: the therapeutic sweet spot
par: Alonzi, D, et autres
Publié: (2017)

Assessment of Target Engagement in a First‐in‐Human Trial with Sinbaglustat, an Iminosugar to Treat Lysosomal Storage Disorders
par: Martine Gehin, et autres
Publié: (2021-03-01)

Use of iminosugar derivatives to inhibit ion channel activity
par: Zitzmann, N, et autres
Publié: (2004)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
par: Priestman, D, et autres
Publié: (2008)

Antiviral effects of an iminosugar derivative on flavivirus infections.
par: Wu, S, et autres
Publié: (2002)

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
par: Boucheron, C, et autres
Publié: (2005)

Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
par: Platt, F, et autres
Publié: (2000)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
par: Andersson, U, et autres
Publié: (2000)

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
par: Steinmann, E, et autres
Publié: (2007)

New developments in treating glycosphingolipid storage diseases.
par: Platt, F, et autres
Publié: (2005)

<i>N</i>-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase
par: Andreas Wolfsgruber, et autres
Publié: (2020-10-01)

A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
par: Kelly L. Warfield, et autres
Publié: (2015-05-01)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
par: Silk, J, et autres
Publié: (2005)

Treating lysosomal storage disorders: current practice and future prospects.
par: Platt, F, et autres
Publié: (2009)

Long alkylchain iminosugars block the HCV p7 ion channel
par: Pavlovic, D, et autres
Publié: (2005)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
par: Gadola, S, et autres
Publié: (2006)

Erratum: Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: The search for new therapeutic agents against Gaucher disease (Tetrahedron: Asymmetry (2005) 16 (1747) DOI: 10.1016/j.tetasy.2005.03. 015)
par: Boucheron, C, et autres
Publié: (2005)

Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.
par: Miller, J, et autres
Publié: (2012)

Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors
par: Kato, A, et autres
Publié: (2015)

Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors.
par: Kato, A, et autres
Publié: (2015)

N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
par: Désiré, J, et autres
Publié: (2014)

Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence
par: Priestman, D, et autres
Publié: (2017)

The mechanism of action of iminosugars as antiretrovirals
par: Spiro, S, et autres
Publié: (2014)